Acceleration of telomere loss by chemotherapy is greater in older patients with locally advanced head and neck cancer

Clinical Cancer Research

Volumn 12, Issue 21, 2006, Pages 6345-6350

  Unryn, Brad M ^a   Hao, Desiree ^b   Glück, Stefan ^c   Riabowol, Karl T ^a  

^a Health Sciences Centre Calgary   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER STAGING; CHEMOTHERAPY; CHROMOSOME LOSS; CHROMOSOME SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA ISOLATION; FEMALE; GROUPS BY AGE; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RESTRICTION FRAGMENT; SEX DIFFERENCE; SMOKING; SQUAMOUS CELL CARCINOMA; TELOMERE;

ADULT; AGE FACTORS; AGED; ANTINEOPLASTIC AGENTS; CISPLATIN; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, SQUAMOUS CELL; RADIOTHERAPY; SEX FACTORS; TELOMERE;

EID: 33751303787     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-06-0486     Document Type: Article

References (35)

1. Olovnikov AM. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol 1973;41:181-90.
2. von Zglinicki T, Pilger R, Sitte N. Accumulation of single-strand breaks is the major cause of telomere shortening in human fibroblasts. Free Radic Biol Med 2000;28:64-74
3. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci U S A 1994;91: 9857-60
4. Unryn BM, Cook LS, Riabowol KT. Paternal age is positively linked to telomere length of children. Aging Cell 2005;4:97-101.
5. Bestilny LJ, Gill MJ, Mody CH, Riabowol KT. Accelerated replicative senescence of the peripheral immune system induced by HIV infection. AIDS 2000;14:771-80.
6. + cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS 1996;10:F17-22.
7. + T cells from HIV-discordant monozygotic twins. J Exp Med 1997;185:1381-6.
8. Richardson MW, Sverstiuk A, Hendel H, Cheung TW, Zagury JF, Rappaport J. Analysis of telomere length and thymic output in fast and slow/non-progressors with HIV infection. Biomed Pharmacother 2000;54: 21-31.
9. Pommier JP, Gauthier L, Livartowski J, et al. Immunosenescence in HIV pathogenesis. Virology 1997;231: 148-54.
10. Browman GP, Hodson DI, Mackenzie RJ, Bestie N, Zuraw L. Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: a systematic review of the published literature with subgroup analysis. Head Neck 2001; 23:579-89.
11. Yee D, Hanson J, Lau H, Siever J, Gluck S. Treatment of nasopharyngeal carcinoma in the modern era: analysis of outcomes and toxicity from a single center in a nonendemic area. Cancer J 2006;12:147-54.
12. Lau H, Brar S, Hao D, Mackinnon J, Yee D, Gluck S. Concomitant low-dose cisplatin and three-dimensional conformal radiotherapy for locally advanced squamous cell carcinoma of the head and neck: analysis of survival and toxicity. Head Neck 2005;28:189-96.
13. Bartelink H, Kallman RF, Rapacchietta D, Hart GA. Therapeutic enhancement in mice by clinically relevant dose and fractionation schedules of cis-diamminedichloroplatinum (II) and irradiation. Radiother Oncol 1986;6:61-74.
14. Kartalou M, Essigmann JM. Mechanisms of resistance to cisplatin. Mutat Res 2001;478:23-43.
15. Reed E, Ozols RF, Tarone R, Yuspa SH, Poirier MC. Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy. Proc Natl Acad Sci U S A 1987;84:5024-8.
16. Reed E, Yuspa SH, Zwelling LA, Ozols RF, Poirier MC. Quantitation of cis-diamminedichloroplatinum II (cisplatin)-DNA-intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy. J Clin Invest 1986;77:545-50.
17. Burstyn JN, Heiger-Bernays WJ, Cohen SM, Lippard SJ. Formation of cis-diamminedichloroplatinum(II) 1,2-intrastrand cross-links on DNA is flanking-sequence independent. Nucleic Acids Res 2000;28: 4237-43.
18. Ricca I, Compagno M, Ladetto M, et al. Marked telomere shortening in mobilized peripheral blood progenitor cells (PBPC) following two tightly spaced high-dose chemotherapy courses with G-CSF. Leukemia 2005;19:644-51.
19. Lee JJ, Nam CE, Cho SH, Park KS, Chung IJ, Kim HJ. Telomere length shortening in non-Hodgkin's lymphoma patients undergoing chemotherapy. Ann Hematol 2003;82:492-5.
20. Franco S, Ozkaynak MF, Sandoval C, et al. Telomere dynamics in childhood leukemia and solid tumors: a follow-up study. Leukemia 2003;17:401-10.
21. Schroder CP, Wisman GB, de Jong S, et al. Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantation. Br J Cancer 2001;84:1348-53.
22. Engelhardt M, Ozkaynak MF, Drullinsky P, et al. Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy. Leukemia 1998;12:13-24.
23. Engelhardt M, Albanell J, Drullinsky P, et al. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma. Clin Cancer Res 1997;3:1849-57.
24. Leteurtre F, Li X, Guardiola P, et al. Accelerated telomere shortening and telomerase activation in Fanconi's anaemia. Br J Haematol 1999;105:883-93.
25. Ball SE, Gibson FM, Rizzo S, Tooze JA, Marsh JC, Gordon-Smith EC. Progressive telomere shortening in aplastic anemia. Blood 1998;91:3582-92.
26. Wu X, Amos CI, Zhu Y, et al. Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst 2003;95:1211-8.
27. McAllister-Sistilli CG, Caggiula AR, Knopf S, Rose CA, Miller AL, Donny EC. The effects of nicotine on the immune system. Psychoneuroendocrinology 1998;23:175-87.
28. Barbour SE, Nakashima K, Zhang JB, et al. Tobacco and smoking: environmental factors that modify the host response (immune system) and have an impact on periodontal health. Crit Rev Oral Biol Med 1997;8: 437-60.
29. + solutions. Nucleic Acids Res 2003; 31:1605-13.
30. Scarpaci S, Frasca D, Barattini P, Guidi L, Doria G. DNA damage recognition and repair capacities in human naive and memory T cells from peripheral blood of young and elderly subjects. Mech Ageing Dev 2003;124:517-24.
31. +) T cells. Braz J Med Biol Res 1991;24:275-9.
32. Weijl NI, Hopman GD, Wipkink-Bakker A, et al. Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients. Ann Oncol 1998;9:1331-7.
33. Saretzki G, Von Zglinicki T. Replicative aging, telomeres, and oxidative stress. Ann N Y Acad Sci 2002; 959:24-9.
34. McCarron M, Osborne Y, Story CJ, Dempsey JL, Turner DR, Morley AA. Effect of age on lymphocyte proliferation. Mech Ageing Dev 1987;41:211-8.
35. Sobin LH, Wittekind C. TNM classification of malignant tumors. 5th ed. New York: Wiley-Liss, Inc.; 1997.